NL302572A - - Google Patents
Info
- Publication number
- NL302572A NL302572A NL302572DA NL302572A NL 302572 A NL302572 A NL 302572A NL 302572D A NL302572D A NL 302572DA NL 302572 A NL302572 A NL 302572A
- Authority
- NL
- Netherlands
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5790262 | 1962-12-27 | ||
| JP5741963 | 1963-10-29 | ||
| JP6427663 | 1963-10-29 | ||
| JP6250163 | 1963-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL302572A true NL302572A (enExample) |
Family
ID=27463499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL302572D NL302572A (enExample) | 1962-12-27 |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE641880A (enExample) |
| FR (1) | FR3150M (enExample) |
| GB (1) | GB1080599A (enExample) |
| LU (1) | LU45106A1 (enExample) |
| NL (1) | NL302572A (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2495608A1 (fr) * | 1980-12-04 | 1982-06-11 | Morelle Jean | Nouveaux derives de l'acide aspartique et leurs usages |
| SI2153870T1 (sl) | 2004-11-26 | 2014-05-30 | Ucl Business Plc | Sestavki, ki obsegajo ornitin in fenilacetat ali fenilbutirat, za zdravljenje hepatitične encefalopatije |
| MX2011010262A (es) | 2009-04-03 | 2012-01-25 | Ocera Therapeutics Inc | Fenil acetato de l-ornitina y metodos para elaborar el mismo. |
| MX2011013129A (es) | 2009-06-08 | 2012-03-14 | Ucl Business Plc | Tratamiento de hipertension portal y restauracion de la funcion hepatica usando fenilacetato de l-ornitina. |
| KR101888215B1 (ko) | 2010-10-06 | 2018-09-20 | 오세라 테라퓨틱스, 아이엔씨. | L-오르니틴 페닐아세테이트의 제조 방법 |
| NZ732632A (en) | 2014-11-24 | 2021-07-30 | Ucl Business Ltd | Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies |
| WO2017031131A1 (en) | 2015-08-18 | 2017-02-23 | Ocera Therapeutics, Inc. | Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate |
| AU2018266357B2 (en) | 2017-05-11 | 2022-12-08 | Ocera Therapeutics, Inc. | Processes of making L-ornithine phenylacetate |
| CN107540413A (zh) * | 2017-09-14 | 2018-01-05 | 精晶药业股份有限公司 | 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法 |
-
0
- NL NL302572D patent/NL302572A/xx unknown
-
1963
- 1963-12-23 GB GB50695/63A patent/GB1080599A/en not_active Expired
- 1963-12-23 LU LU45106D patent/LU45106A1/xx unknown
- 1963-12-26 FR FR958559A patent/FR3150M/fr active Active
- 1963-12-27 BE BE641880A patent/BE641880A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR3150M (fr) | 1965-02-22 |
| GB1080599A (en) | 1967-08-23 |
| LU45106A1 (enExample) | 1964-02-24 |
| BE641880A (enExample) | 1964-04-16 |